Elad Einav | How To Engineer Covered Medical Device Stents

Being an Engineer · 9 Oct 2026 · 45m · Episode 42

What this episode covers

Elad Einav, Co-Founder and CEO of Medibrane, a medical device CDMO specializing in polymer covers for stents, explains the engineering challenges of attaching membranes to metal scaffolds. He details the tradeoffs between traditional sewing, ePTFE sintering, and adhesive-assisted lamination, emphasizing that the covering process must be treated as a composite material design input from day one rather than a downstream manufacturing step. Einav shares examples of field failures, such as stent fractures where the covering remained intact, to illustrate why early integration of material selection, manufacturing processes, and regulatory strategy is critical for clinical success.

Mentioned

Companies
Medibrane, Pipeline Design & Engineering
Materials
ePTFE, Dacron, nitinol

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 9m

    #408: What MedTech Startups Miss: Design Mistakes, Risk Testing & the Myth of the Quick Exit

    Justin Bushko, author of Medical Device Fireside Chats, explains why early-stage MedTech startups fail by ignoring critical engineering details like tolerance stack-up analysis and human factors testing. He highlights the risk of field failures, such as cranial fixation devices breaking under surgeon torque, and emphasizes the need to validate designs with a broad group of Key Opinion Leaders (KOLs) rather than just a few. Bushko advises founders to build sustainable companies with longevity rather than chasing quick licensing deals or acquisitions, noting that acquirers can detect an exit-first mindset.

  • Let's Combinate · 34m

    232 - MedTech Material Selection: Cost, Compliance, Sustainability, and Biocompatibility Risk

    Lucas Pianegonda, founder of Gradical, explains why medtech companies must move away from defaulting to legacy materials or molder preferences toward a structured, data-driven material selection framework. He details how early decisions on polymers like polycarbonate or PTFE impact total cost of goods, regulatory compliance, and sustainability, warning that late changes can cause multi-year delays and expensive retooling. The conversation covers the distinction between material grades and device-level biocompatibility, the risks of PFAS and additives, and the specific requirements of ISO 10993 for toxicological evaluation.

  • Global Medical Device Podcast · 29m

    Overcoming Submission Deficiencies due to Biocompatibility

    Chris Parker, Associate Department Head of In-Vivo Biocompatibility at LabCorp (formerly Toxikon), explains how medical device manufacturers can avoid and resolve FDA submission deficiencies related to biocompatibility. He details the two primary paths for addressing deficiencies—risk assessment/memo or retesting—and emphasizes the importance of proactive engagement with regulatory bodies and toxicologists during the early prototyping phase. The discussion covers material screening for Prop 65 and European CMR regulations, the challenges of testing small-surface-area devices like stents, and the financial impact of remedial work on company timelines.

  • Global Medical Device Podcast · 38m

    #471: From AI Visuals to FDA Approval: Fixing MedTech’s Design-to-Market Gap

    Michael Sprauve, president of Speck Design, explains how MedTech startups often fail by focusing solely on core technology while ignoring the complex web of user personas, including surgeons, nurses, and maintenance staff. He argues that AI-generated visuals frequently lack physical constraints and manufacturing realities, creating a gap between concept and market readiness. To bridge this, Speck Design uses a 'North Star' based on emotional and sensory attributes to guide design, engineering, and CMF choices, ensuring the device meets regulatory and usability needs for all stakeholders. Sprauve emphasizes involving manufacturing engineers from day one to avoid costly re-tooling and ensuring the final product is viable for production and FDA approval.

  • Global Medical Device Podcast · 39m

    #465: Why Good Medical Devices Fail: Reimbursement Strategy with Ali Samiian

    Ali Samiian, founder of Popular Access Advisors, explains why medical device companies fail commercially by treating reimbursement as a post-FDA paperwork exercise rather than a core product strategy. He details how product design, clinical trial endpoints, and regulatory pathways (such as 510(k) vs. De Novo) must align with payer requirements for durable medical equipment (DME) or other categories to ensure coverage. Samiian highlights the importance of demonstrating durability, standard-of-care comparisons, and value to the healthcare system to secure appropriate pricing from CMS and private payers.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Being an Engineer. The episode itself belongs to its publisher.